ArticleJournal of bioenergetics and biomembranes2024
Fragment-based drug design of novel inhibitors targeting lipoprotein (a) kringle domain KIV-10-mediated cardiovascular disease.
Mohammed Alsieni et al.PubMed ↗Publisher ↗
No numbers read from the abstract.